{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:25:56Z","timestamp":1785803156242,"version":"3.56.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2018M3C7A1056275"],"award-info":[{"award-number":["2018M3C7A1056275"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2020R1A2B5B02001468"],"award-info":[{"award-number":["2020R1A2B5B02001468"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jbc.2022.102682","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T11:45:34Z","timestamp":1667821534000},"page":"102682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Glucagon-like peptide-1 analog liraglutide leads to multiple metabolic alterations in diet-induced obese mice"],"prefix":"10.1016","volume":"298","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3932-995X","authenticated-orcid":false,"given":"Seokjae","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5935-088X","authenticated-orcid":false,"given":"Sungjoon","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0631-3660","authenticated-orcid":false,"given":"Eun-Kyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2022.102682_bib1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s42255-020-00327-x","article-title":"Metabolic messengers: glucagon-like peptide 1","volume":"3","author":"Gribble","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.jbc.2022.102682_bib2","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.jbc.2022.102682_bib3","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0140-6736(08)61247-7","article-title":"Treatment of type 2 diabetes with incretin-based therapies","volume":"373","author":"Madsbad","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jbc.2022.102682_bib4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.molmed.2008.01.003","article-title":"Glucagon-like peptide-1, glucose homeostasis and diabetes","volume":"14","author":"Holst","year":"2008","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jbc.2022.102682_bib5","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrendo.2012.140","article-title":"GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus","volume":"8","author":"Meier","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jbc.2022.102682_bib6","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1530\/eje.0.1460863","article-title":"The short half-life of glucagon-like peptide-1 in plasma does not reflect its long-lasting beneficial effects","volume":"146","author":"Hui","year":"2002","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jbc.2022.102682_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes-state of the art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.jbc.2022.102682_bib8","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41574-018-0016-2","article-title":"Glucagon-like peptide 1 in health and disease","volume":"14","author":"Andersen","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jbc.2022.102682_bib9","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1056\/NEJMp1001578","article-title":"Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy","volume":"362","author":"Parks","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jbc.2022.102682_bib10","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1124\/dmd.110.034066","article-title":"Metabolism and excretion of the once-daily human glucagon-like peptide 1 analog liraglutide in healthy male subjects and its in\u00a0vitro degradation by dipeptidyl peptidase IV and neutral endopeptidase","volume":"38","author":"Malm-Erjefalt","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jbc.2022.102682_bib11","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.2337\/diabetes.50.11.2530","article-title":"Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats","volume":"50","author":"Larsen","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.jbc.2022.102682_bib12","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1021\/jm9909645","article-title":"Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration","volume":"43","author":"Knudsen","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2022.102682_bib13","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13300-016-0180-0","article-title":"Clinical effectiveness of liraglutide in type 2 diabetes treatment in the real-world setting: a systematic literature review","volume":"7","author":"Ostawal","year":"2016","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.jbc.2022.102682_bib14","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0140-6736(09)61375-1","article-title":"Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study","volume":"374","author":"Astrup","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jbc.2022.102682_bib15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jama.2015.9676","article-title":"Efficacy of liraglutide for weight loss among patients with type 2 diabetes: the SCALE diabetes randomized clinical trial","volume":"314","author":"Davies","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jbc.2022.102682_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A\u00a0randomized, controlled trial of 3.0 mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.jbc.2022.102682_bib17","first-page":"407","article-title":"Effect of liraglutide therapy on liver fat content in patients with inadequately controlled type 2 diabetes: the lira-NAFLD Study","volume":"102","author":"Petit","year":"2017","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2022.102682_bib18","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1161\/CIRCULATIONAHA.118.034516","article-title":"Effects of liraglutide on cardiovascular outcomes in patients with type 2 diabetes mellitus with or without history of myocardial infarction or stroke","volume":"138","author":"Verma","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jbc.2022.102682_bib19","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1056\/NEJMoa2028198","article-title":"Healthy weight loss maintenance with exercise, liraglutide, or both combined","volume":"384","author":"Lundgren","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jbc.2022.102682_bib20","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.2337\/db14-0302","article-title":"GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK","volume":"63","author":"Beiroa","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.jbc.2022.102682_bib21","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1172\/JCI75276","article-title":"The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss","volume":"124","author":"Secher","year":"2014","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jbc.2022.102682_bib22","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.2337\/dc06-2593","article-title":"Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes","volume":"30","author":"Vilsboll","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jbc.2022.102682_bib23","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3389\/fendo.2018.00672","article-title":"Pleiotropic effects of GLP-1 and analogs on cell signaling, metabolism, and function","volume":"9","author":"Rowlands","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.jbc.2022.102682_bib24","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.metabol.2014.05.008","article-title":"Liraglutide enhances glucose transporter 4 translocation via regulation of AMP-activated protein kinase signaling pathways in mouse skeletal muscle cells","volume":"63","author":"Li","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.jbc.2022.102682_bib25","doi-asserted-by":"crossref","first-page":"587","DOI":"10.14348\/molcells.2015.0126","article-title":"A\u00a0metabolomic approach to understanding the metabolic link between obesity and diabetes","volume":"38","author":"Park","year":"2015","journal-title":"Mol. Cells"},{"key":"10.1016\/j.jbc.2022.102682_bib26","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.2337\/db09-0580","article-title":"Metabolomics applied to diabetes research: moving from information to knowledge","volume":"58","author":"Bain","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.jbc.2022.102682_bib27","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.cmet.2018.09.022","article-title":"Profound perturbation of the metabolome in obesity is associated with health risk","volume":"29","author":"Cirulli","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.jbc.2022.102682_bib28","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrd.2016.32","article-title":"Emerging applications of metabolomics in drug discovery and precision medicine","volume":"15","author":"Wishart","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jbc.2022.102682_bib29","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jcjd.2019.05.008","article-title":"Metformin and dipeptidyl peptidase-4 inhibitor differentially modulate the intestinal microbiota and plasma metabolome of metabolically dysfunctional mice","volume":"44","author":"Ryan","year":"2020","journal-title":"Can J. Diabetes"},{"key":"10.1016\/j.jbc.2022.102682_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.609806","article-title":"Distinctive metabolomics patterns associated with insulin resistance and type 2 diabetes mellitus","volume":"7","author":"Gu","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.jbc.2022.102682_bib31","article-title":"Obesity connected metabolic changes in type 2 diabetic patients treated with metformin","volume":"11","author":"Aleidi","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jbc.2022.102682_bib32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12010-018-2899-8","article-title":"Metabolomics based on MS in mice with diet-induced obesity and type 2 diabetes mellitus: the effect of vildagliptin, metformin, and their combination","volume":"188","author":"Tomasova","year":"2019","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.jbc.2022.102682_bib33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1530\/JOE-16-0478","article-title":"The effects of liraglutide in mice with diet-induced obesity studied by metabolomics","volume":"233","author":"Buganova","year":"2017","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.jbc.2022.102682_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073076","article-title":"The human urine metabolome","volume":"8","author":"Bouatra","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2022.102682_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104873","article-title":"Divergent effects of liraglutide, exendin-4, and sitagliptin on beta-cell mass and indicators of pancreatitis in a mouse model of hyperglycaemia","volume":"9","author":"Mondragon","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2022.102682_bib36","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12020-018-1826-7","article-title":"Liraglutide induces beige fat development and promotes mitochondrial function in diet induced obesity mice partially through AMPK-SIRT-1-PGC1-alpha cell signaling pathway","volume":"64","author":"Zhou","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.jbc.2022.102682_bib37","doi-asserted-by":"crossref","first-page":"8302","DOI":"10.1523\/JNEUROSCI.1668-09.2009","article-title":"Mediobasal hypothalamic leucine sensing regulates food intake through activation of a hypothalamus-brainstem circuit","volume":"29","author":"Blouet","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jbc.2022.102682_bib38","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.cmet.2008.03.006","article-title":"Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin","volume":"7","author":"Lopez","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.jbc.2022.102682_bib39","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/35007534","article-title":"Central nervous system control of food intake","volume":"404","author":"Schwartz","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2022.102682_bib40","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s42255-021-00408-5","article-title":"Central nervous system regulation of organismal energy and glucose homeostasis","volume":"3","author":"Myers","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.jbc.2022.102682_bib41","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/oby.21387","article-title":"Effects of liraglutide in hypothalamic arcuate nucleus of obese mice","volume":"24","author":"Barreto-Vianna","year":"2016","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jbc.2022.102682_bib42","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.molmet.2019.07.008","article-title":"Direct and indirect effects of liraglutide on hypothalamic POMC and NPY\/AgRP neurons - implications for energy balance and glucose control","volume":"28","author":"He","year":"2019","journal-title":"Mol. Metab."},{"key":"10.1016\/j.jbc.2022.102682_bib43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/mas.20108","article-title":"Mass spectrometry-based metabolomics","volume":"26","author":"Dettmer","year":"2007","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.jbc.2022.102682_bib44","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1172\/JCI36714","article-title":"Palmitic acid mediates hypothalamic insulin resistance by altering PKC-theta subcellular localization in rodents","volume":"119","author":"Benoit","year":"2009","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jbc.2022.102682_bib45","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1210\/en.2010-0659","article-title":"Low-grade hypothalamic inflammation leads to defective thermogenesis, insulin resistance, and impaired insulin secretion","volume":"152","author":"Arruda","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.jbc.2022.102682_bib46","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2337\/diabetes.51.2.271","article-title":"Central administration of oleic acid inhibits glucose production and food intake","volume":"51","author":"Obici","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.jbc.2022.102682_bib47","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nm1201","article-title":"Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis","volume":"11","author":"Lam","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbc.2022.102682_bib48","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2174\/1389450117666151209120345","article-title":"Implications of palmitoleic acid (Palmitoleate) on glucose homeostasis, insulin resistance and diabetes","volume":"18","author":"Nunes","year":"2017","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.jbc.2022.102682_bib49","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1530\/JOE-18-0374","article-title":"The key role of a glucagon-like peptide-1 receptor agonist in body fat redistribution","volume":"240","author":"Zhao","year":"2019","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.jbc.2022.102682_bib50","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","article-title":"A\u00a0branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance","volume":"9","author":"Newgard","year":"2009","journal-title":"Cell Metab."},{"key":"10.1016\/j.jbc.2022.102682_bib51","doi-asserted-by":"crossref","first-page":"24795","DOI":"10.1074\/jbc.M112.344259","article-title":"Leucine stimulates insulin secretion via down-regulation of surface expression of adrenergic alpha2A receptor through the mTOR (mammalian target of rapamycin) pathway: implication in new-onset diabetes in renal transplantation","volume":"287","author":"Yang","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2022.102682_bib52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40104-016-0139-z","article-title":"Novel metabolic and physiological functions of branched chain amino acids: a review","volume":"8","author":"Zhang","year":"2017","journal-title":"J.\u00a0Anim. Sci. Biotechnol."},{"key":"10.1016\/j.jbc.2022.102682_bib53","doi-asserted-by":"crossref","DOI":"10.1177\/20406223221077958","article-title":"Nicotinamide supplementation in diabetic nonalcoholic fatty liver disease patients: randomized controlled trial","volume":"13","author":"El-Kady","year":"2022","journal-title":"Ther. Adv. Chronic Dis."},{"key":"10.1016\/j.jbc.2022.102682_bib54","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1021\/pr400051s","article-title":"Early metabolic adaptation in C57BL\/6 mice resistant to high fat diet induced weight gain involves an activation of mitochondrial oxidative pathways","volume":"12","author":"Boulange","year":"2013","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.jbc.2022.102682_bib55","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1079\/BJN19860138","article-title":"The metabolism of high intakes of tryptophan, nicotinamide and nicotinic acid in the rat","volume":"56","author":"McCreanor","year":"1986","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.jbc.2022.102682_bib56","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/BF01973715","article-title":"Taurine, a possible urinary marker of liver damage: a study of taurine excretion in carbon tetrachloride-treated rats","volume":"65","author":"Waterfield","year":"1991","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.jbc.2022.102682_bib57","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1039\/C5FO01295C","article-title":"The beneficial effects of taurine in preventing metabolic syndrome","volume":"7","author":"Chen","year":"2016","journal-title":"Food Funct."},{"key":"10.1016\/j.jbc.2022.102682_bib58","doi-asserted-by":"crossref","first-page":"104351","DOI":"10.1016\/j.jff.2020.104351","article-title":"The beneficial effects of taurine in alleviating fatty liver disease","volume":"77","author":"Song","year":"2021","journal-title":"J.\u00a0Funct. Foods"},{"key":"10.1016\/j.jbc.2022.102682_bib59","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3390\/metabo12060524","article-title":"Taurine ameliorates streptozotocin-induced diabetes by modulating hepatic glucose metabolism and oxidative stress in mice","volume":"12","author":"Murakami","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.jbc.2022.102682_bib60","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat3392","article-title":"Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models","volume":"10","author":"Killion","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jbc.2022.102682_bib61","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1007\/s00125-015-3651-3","article-title":"Contribution of brown adipose tissue activity to the control of energy balance by GLP-1 receptor signalling in mice","volume":"58","author":"Heppner","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.jbc.2022.102682_bib62","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3390\/metabo12050407","article-title":"Metabolic profiling of the hypothalamus of mice during short-term food deprivation","volume":"12","author":"Kim","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.jbc.2022.102682_bib63","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200176","article-title":"Metabolomics of human fasting: new insights about old questions","volume":"10","author":"Kondoh","year":"2020","journal-title":"Open Biol."},{"key":"10.1016\/j.jbc.2022.102682_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2020.110875","article-title":"Impact of calorie restriction on energy metabolism in humans","volume":"133","author":"Most","year":"2020","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.jbc.2022.102682_bib65","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12986-022-00674-4","article-title":"Comprehensive evaluation of caloric restriction-induced changes in the metabolome profile of mice","volume":"19","author":"Xie","year":"2022","journal-title":"Nutr. Metab. (Lond)"},{"key":"10.1016\/j.jbc.2022.102682_bib66","doi-asserted-by":"crossref","first-page":"6463","DOI":"10.1038\/s41467-021-26654-5","article-title":"Diet composition influences the metabolic benefits of short cycles of very low caloric intake","volume":"12","author":"Diaz-Ruiz","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2022.102682_bib67","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1210\/jc.2017-01020","article-title":"A\u00a0metabolomic signature of acute caloric restriction","volume":"102","author":"Collet","year":"2017","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2022.102682_bib68","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abb2490","article-title":"Metabolic adaptation to calorie restriction","volume":"13","author":"Guijas","year":"2020","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jbc.2022.102682_bib69","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nmeth.4512","article-title":"Identifying metabolites by integrating metabolome databases with mass spectrometry cheminformatics","volume":"15","author":"Lai","year":"2018","journal-title":"Nat. Met."},{"key":"10.1016\/j.jbc.2022.102682_bib70","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nmeth.3393","article-title":"MS-DIAL: data-independent MS\/MS deconvolution for comprehensive metabolome analysis","volume":"12","author":"Tsugawa","year":"2015","journal-title":"Nat. Met."},{"key":"10.1016\/j.jbc.2022.102682_bib71","doi-asserted-by":"crossref","first-page":"W388","DOI":"10.1093\/nar\/gkab382","article-title":"MetaboAnalyst 5.0: nnarrowing the gap between raw spectra and functional insights","volume":"49","author":"Pang","year":"2021","journal-title":"Nucl. Acids Res."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925822011255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925822011255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:32:58Z","timestamp":1758241978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925822011255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":71,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0021925822011255"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2022.102682","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagon-like peptide-1 analog liraglutide leads to multiple metabolic alterations in diet-induced obese mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2022.102682","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"102682"}}